Zobrazeno 1 - 10
of 23
pro vyhledávání: '"J. B. Ulmer"'
Publikováno v:
Journal of Drug Targeting. 11:481-488
The discovery that genes can be functionally transferred from bacteria to mammalian cells has suggested the possible use of bacterial vectors as gene delivery vehicles for vaccines. Attenuated invasive human intestinal bacteria, such as Salmonella an
Publikováno v:
Pharmacology & Therapeutics. 74:195-205
In just a few years, injection of plasmid DNA to elicit immune responses in vivo has developed from an interesting observation to a viable vaccine strategy. DNA vaccines have been shown to elicit both cellular and humoral immune responses and to be e
Publikováno v:
Current Opinion in Immunology. 8:531-536
Preclinical DNA vaccine development has continued apace during the past year, with the investigation of several new infectious and non-infectious disease targets as well as advances in our understanding of some of the basic immunologic mechanisms, su
Publikováno v:
Methods in molecular medicine. 4
The use of DNA and mRNA as vectors for immunization is a relatively recent development in the field of vaccines. The first paper demonstrating the efficacy of a DNA vaccine in an animal model of viral disease was published in 1993 (1). The rationale
Autor:
J B, Ulmer
Publikováno v:
Current opinion in drug discoverydevelopment. 4(2)
DNA vaccines have been extensively studied in the past ten years and much is now known about their effectiveness and mode of action in animal models. Several DNA vaccines have been tested in phase I clinical trials, with mixed results. That is, DNA v
Autor:
A Y, Lee, W C, Manning, C L, Arian, N K, Polakos, J L, Barajas, J B, Ulmer, M, Houghton, X, Paliard
Publikováno v:
Hepatology (Baltimore, Md.). 31(6)
The immunology of hepatitis C virus (HCV) infection should be studied in the context of HCV antigen expression in the liver, because HCV primarily infects this organ. Indeed, the nature, function, and fate of T cells primed after antigen expression i
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 162(7)
Intramuscular injection of BALB/c mice with a DNA plasmid encoding nucleoprotein (NP) from influenza virus A/PR/8/34 (H1N1) provides cross-strain protection against lethal challenge with influenza virus A/HK/68 (H3N2). CTL specific for the H-2Kd-rest
Publikováno v:
Advances in experimental medicine and biology. 452
Publikováno v:
Vaccines ISBN: 9783642641961
DNA vaccination is a novel vaccine technology that is being developed for a variety of clinical applications, as well as being utilized as a tool for exploring basic questions related to antigen processing and presentation. DNA vaccines differ from t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::440f6701657d28c3606a8e524a0fcf25
https://doi.org/10.1007/978-3-642-59955-2_3
https://doi.org/10.1007/978-3-642-59955-2_3
Publikováno v:
Developments in biological standardization. 95
Immunization with plasmid DNA encoding antigenic proteins elicits both antibody and cell-mediated immune responses. This method of producing the protein antigens of interest directly in host cells can provide appropriate tertiary structure for the in